Company / Current Liabilities per Share
BioRestorative Therapies, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.54
FY2025
5-year range
$0.13 / $0.80
FY2021-FY2025
Trend
-32.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2020 to $1.78 in FY2017.
Based on SEC 10-K filings.
0.54 in FY2025 with a 5-year CAGR of +109.2%.
Improved from $0.71 to $0.54 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +62.6%
- 5-Year CAGR
- +109.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 32.4% year-over-year.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | -32.4% |
| FY2024 | $0.80 | +12.3% |
| FY2023 | $0.71 | +466.8% |
| FY2022 | $0.13 | -75.4% |
| FY2021 | $0.51 | +3688.7% |
| FY2020 | $0.01 | -98.9% |
| FY2019 | $1.17 | -22.7% |
| FY2018 | $1.51 | -14.8% |
| FY2017 | $1.78 | +0.7% |
| FY2016 | $1.77 | -46.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026